University of Pittsburgh Medical Center - Hillman Cancer Center is a clinical research site located in Pittsburgh, Pennsylvania, United States 15232.
Crixeo Health Trust Score: 77/100 (FAIR). This profile has not yet been claimed by the site owner.
University of Pittsburgh Medical Center - Hillman Cancer Center has participated in 12 clinical trials with 6 currently active.
Therapeutic areas: Chronic Graft-versus-host-disease, Glioblastoma, Metastatic Head-and-neck Squamous-cell Carcinoma.
Sponsors: Syndax Pharmaceuticals, Global Coalition for Adaptive Research, AVEO Pharmaceuticals, Inc..
Trust Score: 77/100. Verification status: Crixeo Accredited. Patient reviews: 0. Complaints: 0.
University of Pittsburgh Medical Center - Hillman Cancer Center has a Crixeo Trust Score of 77/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
University of Pittsburgh Medical Center - Hillman Cancer Center has 12 clinical trials on record, with 6 currently active. Their work covers Chronic Graft-versus-host-disease, Glioblastoma, Metastatic Head-and-neck Squamous-cell Carcinoma.
Yes — University of Pittsburgh Medical Center - Hillman Cancer Center holds Crixeo Accreditation, the quality standard for clinical research sites. Accredited sites have verified compliance documents, strong patient reviews, and sponsor transparency.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.